Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Societal CDMO's Pre-Tax Income for the
three
months ended in Dec. 2023 was $-0.77 Mil. Societal CDMO's Revenue for the
three
months ended in Dec. 2023 was $27.72 Mil. Therefore, Societal CDMO's pretax margin for the quarter that ended in Dec. 2023 was -2.77%.
The historical rank and industry rank for Societal CDMO's Pretax Margin % or its related term are showing as below:
SCTL'
s Pretax Margin % Range Over the Past 10 Years
Min: -45.16 Med: -15.09 Max: 5.65
Current: -13.89
SCTL's Pretax Margin % is ranked worse than 70.94% of 1022
companies
in the Drug Manufacturers industry
Industry Median: 4.555
vs SCTL: -13.89
Societal CDMO Pretax Margin % Historical Data
The historical data trend for Societal CDMO's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Societal CDMO's Pretax Margin %
For the Drug Manufacturers - Specialty & Generic subindustry, Societal CDMO's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Societal CDMO's Pretax Margin % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Societal CDMO's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Societal CDMO's Pretax Margin % falls into.
Societal CDMO Pretax Margin % Calculation
Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.
Societal CDMO's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Societal CDMO Pretax Margin % Related Terms
Thank you for viewing the detailed overview of Societal CDMO's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Societal CDMO (Societal CDMO) Business Description
Societal CDMO Inc is a bi-coastal contract development and manufacturing organization. It offers capabilities spanning pre-Investigational New Drug development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms primarily focused on small molecules. The company also provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging, and logistics services to the global pharmaceutical market.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SCTL has been successfully added to your 